Comparative efficacy and safety of MAOIs versus TCAs in treating depression in the elderly

[1]  J. Mann,et al.  Resistant geriatric depressions and therapeutic response to monoamine oxidase inhibitors. , 1983, Biological psychiatry.

[2]  B. Reisberg,et al.  The Global Deterioration Scale for assessment of primary degenerative dementia. , 1982, The American journal of psychiatry.

[3]  J. Mann,et al.  Platelet monoamine oxidase inhibition as a potential indicator of favorable response to MAOI's in geriatric depressions. , 1981, Biological psychiatry.

[4]  R. L. Bruno,et al.  Comparison of imipramine- and nortriptyline-induced orthostatic hypotension: a meaningful difference. , 1981, Journal of clinical psychopharmacology.

[5]  D. Blazer,et al.  Epidemiology of dysphoria and depression in an elderly population. , 1980, The American journal of psychiatry.

[6]  Ashford Jw,et al.  Use of MAO Inhibitors in Elderly Patients , 1979 .

[7]  E. Robins,et al.  Research diagnostic criteria: rationale and reliability. , 1978, Archives of general psychiatry.

[8]  J. Ives,et al.  Clinical pharmacology of phenelzine. , 1978, Archives of general psychiatry.

[9]  R. Braithwaite,et al.  High plasma nortriptyline levels in the treatment of depression. I , 1978, Clinical pharmacology and therapeutics.

[10]  T. Cooper,et al.  Relationship between age and tricyclic antidepressant plasma levels. , 1977, The American journal of psychiatry.

[11]  J. Biggs,et al.  Amitriptyline plasma levels and therapeutic response , 1976, Clinical pharmacology and therapeutics.

[12]  E. Robins,et al.  Research diagnostic criteria. , 1975, Psychopharmacology bulletin.

[13]  M. Åsberg,et al.  Plasma-nortriptyline levels in endogenous depression. , 1973, Lancet.

[14]  A. Diosy.  Monoamine oxidase inhibitors , 1984 .

[15]  M. Åsberg,et al.  Relationship between Plasma Level and Therapeutic Effect of Nortriptyline , 1971, British medical journal.

[16]  C. Shamoian.  Treatment of affective disorders in the elderly , 1985 .

[17]  A. Georgotas.  Affective disorders in the elderly: diagnostic and research considerations. , 1983, Age and ageing.

[18]  T. Cooper,et al.  The treatment of affective disorders in the elderly. , 1983, Psychopharmacology bulletin.

[19]  E. Paykel.  Handbook of affective disorders , 1982 .

[20]  P. Cross,et al.  The epidemiology of depression and dementia in the elderly: the use of multiple indicators of these conditions. , 1980, Proceedings of the annual meeting of the American Psychopathological Association.

[21]  J. Barrett,et al.  Psychopathology in the aged , 1980 .

[22]  A. Raskin.  Adverse reactions to phenelzine: results of a nine-hospital depression study. , 1972, The Journal of clinical pharmacology and new drugs.